2nd Mastering HR Summit 2011

26 - 27 October 2011, Amsterdam, Netherlands.
North West Business GroupNorth West Business Group invites to attend the 2nd Mastering HR 2011 Conference, geared towards Vice Presidents, Directors, and Managers involved in Talent, recruitment and compensation and benefits. Based on the success of the previous Mastering HR conference in March 2011, the hot topics for a one-stop shop approach to international HR issues have been combined.

Driven by increasing recognition of the importance of human capital in today's competitive market, the organization's expectation of HR is continuously getting higher. The role of HR is evolving from an operational department to a strategic one. HR professionals need to advance their skills and equip the team with new and ever-changing ideas. Attending this exclusive conference will bring together top experts from across Europe for a very intensive and interactive meeting. Benefit from the hands-on approach and unique case studies from top players in the industry. This forum sets a platform for practitioners from around the world to discuss and share strategies for their future success.

The event will focus on the most current topics in the HR industry such as:

  • A Cohesive Approach to Recruiting, Hiring and Accelerating Talent
  • Utilizing Social Media to Reach Specific Skill Set Employees
  • Evaluating Current Trends In Recruitment And Retention
  • How Connecting Performance Management And Talent is going to help you?
  • Using Talent Development Programs As A Vehicle For The Corporate Strategy
  • Recruiting the Best Talent By Selling More Than Just A Salary - The Role Of Culture
  • Effective Remuneration Planning To Succeed In a Tight Labour Market
  • Effectively Communicating Remuneration And Benefits To Employees
  • How Recognition and Reward Can Motivate Employees to Build and Deliver Authentic Brand Experiences

Joins some of the experts like:

  • Genzyme, Vice President HR - European Commercial, CDMA
  • TeliaSonera, Vice President & HR Business Partner
  • Santander, Head of Talent Development & Performance
  • SAP, Director Learning & Talent Management
  • KPN, HR Director
  • IBM HR, Director Benelux
  • Astellas Pharma, Director Human Resources
  • Accenture, Country Director HR
  • Pfizer, Talent Acquisition COE Lead
  • Heinz, Director Compensation & Benefits
  • Zurich Financial Services, UK Head of Resourcing
  • IBM, Workforce Partner Benelux
  • UBS, HR Executive Director
  • Magnate Global Group MGG, Group CHRO
  • European Personnel Selection Office, Director of EPSO
  • IBM HR, Director Benelux
  • And many more ...

Who should attend?
This conference is designed to attract key decision makers from the HR industry with key job titles including: Managing Directors, Country Managers, General Managers, Vice Presidents, Regional Directors/Heads, Directors, Department Heads, Managers, etc.

Benefits of attending include:

  • Hearing from experts actively working in the industry
  • Participating in the panel discussions
  • Quizzing industry experts on the ideas that worked
  • Exchanging ideas with senior professionals across Europe

For further information and registration, please visit:
http://www.nwbg.eu/all-events/2nd-master-hr-sumit-2011/

Most Popular Now

Cancer cells are quick-change artists adapting to …

Until now, researchers have assumed that the growth of solid tumors originates from cancer stem cells characterized by specific surface markers, which develop in a fixed...

Nucala (mepolizumab) gains FDA approval for two ne…

GlaxoSmithKline (LSE/NYSE: GSK) announced that the US Food and Drug Administration (FDA) has approved two new methods for administering Nucala (mepolizumab), an autoinjec...

Jeff Settleman, Ph.D., joins Pfizer to lead Oncolo…

Pfizer Inc. (NYSE: PFE) announced that Jeff Settleman, Ph.D., will join the company as Senior Vice President and Group Head of Oncology Research & Development, leading al...

Cannabis use among older adults rising rapidly

Cannabis use among older adults is growing faster than any other age group but many report barriers to getting medical marijuana, a lack of communication with their docto...

Full data from CAROLINA® outcome trial support lon…

Boehringer Ingelheim and Eli Lilly and Company (NYSE: LLY) announced full data from the CAROLINA® trial demonstrating that Trajenta® (linagliptin) did not increase cardio...

Cleveland researchers test novel gene therapy for …

A novel gene therapy clinical trial at University Hospitals Seidman Cancer Center and the Case Comprehensive Cancer Center is showing promising results, garnering funding...

Merck pioneers new effort to see MS from the insid…

Merck, a leading science and technology company, joins the global multiple sclerosis (MS) community in recognition of World MS Day, an initiative created by the Multiple ...

Bristol-Myers Squibb announces post-closing leader…

Bristol-Myers Squibb Company (NYSE:BMY) today announced the future leadership team of the combined company effective upon completion of the company’s pending merger with ...

Novartis Kisqali significantly extends life in wom…

Novartis announced statistically significant overall survival (OS) results for Kisqali in combination with endocrine therapy[1]. The Phase 3 MONALEESA-7 trial evaluated K...

Amgen joins with community oncology networks for n…

Amgen (NASDAQ: AMGN), along with leading community oncology networks, today announced the launch of Amgen Community Oncology Research Collaborators (ACORC), a new initiat...

Bayer receives U.S. FDA breakthrough therapy desig…

Bayer announced today that the U.S. Food and Drug Administration (FDA) granted Breakthrough Therapy Designation for copanlisib (Aliqopa™) for the treatment of adult patie...

Prescription drug costs steadily soar, yet price t…

After reviewing tens of millions of insurance claims for the country’s 49 most popular brand-name prescription drugs, a team from Scripps Research Translational Institute...